IBDEI07N ; ; 20-FEB-2013
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 20, 2013
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,10050,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10050,1,3,0)
 ;;=3^Choroidal Rupture
 ;;^UTILITY(U,$J,358.3,10050,1,4,0)
 ;;=4^363.63
 ;;^UTILITY(U,$J,358.3,10050,2)
 ;;=Choroidal Rupture^268698
 ;;^UTILITY(U,$J,358.3,10051,0)
 ;;=379.22^^79^675^3
 ;;^UTILITY(U,$J,358.3,10051,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10051,1,3,0)
 ;;=3^Asteroid Hyalosis
 ;;^UTILITY(U,$J,358.3,10051,1,4,0)
 ;;=4^379.22
 ;;^UTILITY(U,$J,358.3,10051,2)
 ;;=Asteroid Hyalosis^269310
 ;;^UTILITY(U,$J,358.3,10052,0)
 ;;=379.21^^79^675^57
 ;;^UTILITY(U,$J,358.3,10052,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10052,1,3,0)
 ;;=3^Vitreous Detachment/Degeneration (Pvd)
 ;;^UTILITY(U,$J,358.3,10052,1,4,0)
 ;;=4^379.21
 ;;^UTILITY(U,$J,358.3,10052,2)
 ;;=Vitreous Detachment/Degeneration^88242
 ;;^UTILITY(U,$J,358.3,10053,0)
 ;;=379.24^^79^675^58
 ;;^UTILITY(U,$J,358.3,10053,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10053,1,3,0)
 ;;=3^Vitreous Floaters
 ;;^UTILITY(U,$J,358.3,10053,1,4,0)
 ;;=4^379.24
 ;;^UTILITY(U,$J,358.3,10053,2)
 ;;=Vitreous Floaters^88242
 ;;^UTILITY(U,$J,358.3,10054,0)
 ;;=379.26^^79^675^60
 ;;^UTILITY(U,$J,358.3,10054,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10054,1,3,0)
 ;;=3^Vitreous Prolapse
 ;;^UTILITY(U,$J,358.3,10054,1,4,0)
 ;;=4^379.26
 ;;^UTILITY(U,$J,358.3,10054,2)
 ;;=Vitreous Prolapse^269312
 ;;^UTILITY(U,$J,358.3,10055,0)
 ;;=379.23^^79^675^59
 ;;^UTILITY(U,$J,358.3,10055,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10055,1,3,0)
 ;;=3^Vitreous Hemorrhage
 ;;^UTILITY(U,$J,358.3,10055,1,4,0)
 ;;=4^379.23
 ;;^UTILITY(U,$J,358.3,10055,2)
 ;;=Vitreous Hemorrhage^127096
 ;;^UTILITY(U,$J,358.3,10056,0)
 ;;=362.18^^79^675^47
 ;;^UTILITY(U,$J,358.3,10056,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10056,1,3,0)
 ;;=3^Retinal Vasculitis
 ;;^UTILITY(U,$J,358.3,10056,1,4,0)
 ;;=4^362.18
 ;;^UTILITY(U,$J,358.3,10056,2)
 ;;=Retinal Vasculitis^264463
 ;;^UTILITY(U,$J,358.3,10057,0)
 ;;=360.21^^79^675^19
 ;;^UTILITY(U,$J,358.3,10057,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10057,1,3,0)
 ;;=3^Degenerative Myopia
 ;;^UTILITY(U,$J,358.3,10057,1,4,0)
 ;;=4^360.21
 ;;^UTILITY(U,$J,358.3,10057,2)
 ;;=Degenerative Myopia^268553
 ;;^UTILITY(U,$J,358.3,10058,0)
 ;;=362.64^^79^675^43
 ;;^UTILITY(U,$J,358.3,10058,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10058,1,3,0)
 ;;=3^Reticular Degeneration
 ;;^UTILITY(U,$J,358.3,10058,1,4,0)
 ;;=4^362.64
 ;;^UTILITY(U,$J,358.3,10058,2)
 ;;=Reticular Degeneration^268645
 ;;^UTILITY(U,$J,358.3,10059,0)
 ;;=362.61^^79^675^17
 ;;^UTILITY(U,$J,358.3,10059,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10059,1,3,0)
 ;;=3^Degeneration, Paving Stone
 ;;^UTILITY(U,$J,358.3,10059,1,4,0)
 ;;=4^362.61
 ;;^UTILITY(U,$J,358.3,10059,2)
 ;;=Paving Stone Degeneration^268642
 ;;^UTILITY(U,$J,358.3,10060,0)
 ;;=362.42^^79^675^51
 ;;^UTILITY(U,$J,358.3,10060,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10060,1,3,0)
 ;;=3^Rpe Detachment, Serous
 ;;^UTILITY(U,$J,358.3,10060,1,4,0)
 ;;=4^362.42
 ;;^UTILITY(U,$J,358.3,10060,2)
 ;;=Serous RPE Detachment^268633
 ;;^UTILITY(U,$J,358.3,10061,0)
 ;;=362.43^^79^675^50
 ;;^UTILITY(U,$J,358.3,10061,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10061,1,3,0)
 ;;=3^Rpe Detachment, Hemorrhagic
 ;;^UTILITY(U,$J,358.3,10061,1,4,0)
 ;;=4^362.43
 ;;^UTILITY(U,$J,358.3,10061,2)
 ;;=Hemorrhagic RPE Detachment^268634
 ;;^UTILITY(U,$J,358.3,10062,0)
 ;;=250.00^^79^675^22
 ;;^UTILITY(U,$J,358.3,10062,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10062,1,3,0)
 ;;=3^Dm Type II, No Retinopathy
 ;;^UTILITY(U,$J,358.3,10062,1,4,0)
 ;;=4^250.00
 ;;^UTILITY(U,$J,358.3,10062,2)
 ;;=DM Type II, No Retinopathy^33605
 ;;^UTILITY(U,$J,358.3,10063,0)
 ;;=250.01^^79^675^21
 ;;^UTILITY(U,$J,358.3,10063,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10063,1,3,0)
 ;;=3^Dm Type I, No Retinopathy
 ;;^UTILITY(U,$J,358.3,10063,1,4,0)
 ;;=4^250.01
 ;;^UTILITY(U,$J,358.3,10063,2)
 ;;=DM Type I, No Retinopathy^33586
 ;;^UTILITY(U,$J,358.3,10064,0)
 ;;=250.50^^79^675^15
 ;;^UTILITY(U,$J,358.3,10064,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10064,1,3,0)
 ;;=3^Csme In DM Type II
 ;;^UTILITY(U,$J,358.3,10064,1,4,0)
 ;;=4^250.50
 ;;^UTILITY(U,$J,358.3,10064,2)
 ;;=CSME in DM type II^267839^362.83
 ;;^UTILITY(U,$J,358.3,10065,0)
 ;;=250.51^^79^675^14
 ;;^UTILITY(U,$J,358.3,10065,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10065,1,3,0)
 ;;=3^Csme In Dm Type I
 ;;^UTILITY(U,$J,358.3,10065,1,4,0)
 ;;=4^250.51
 ;;^UTILITY(U,$J,358.3,10065,2)
 ;;=CSME in DM Type I^267840^362.83
 ;;^UTILITY(U,$J,358.3,10066,0)
 ;;=362.01^^79^675^20
 ;;^UTILITY(U,$J,358.3,10066,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10066,1,3,0)
 ;;=3^Diabetic Retinopathy Nos
 ;;^UTILITY(U,$J,358.3,10066,1,4,0)
 ;;=4^362.01
 ;;^UTILITY(U,$J,358.3,10066,2)
 ;;=^12257
 ;;^UTILITY(U,$J,358.3,10067,0)
 ;;=362.02^^79^675^40
 ;;^UTILITY(U,$J,358.3,10067,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10067,1,3,0)
 ;;=3^Prolif Diab Retinopathy
 ;;^UTILITY(U,$J,358.3,10067,1,4,0)
 ;;=4^362.02
 ;;^UTILITY(U,$J,358.3,10067,2)
 ;;=^268610
 ;;^UTILITY(U,$J,358.3,10068,0)
 ;;=362.03^^79^675^36
 ;;^UTILITY(U,$J,358.3,10068,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10068,1,3,0)
 ;;=3^Nonprolf Db Retnoph Nos
 ;;^UTILITY(U,$J,358.3,10068,1,4,0)
 ;;=4^362.03
 ;;^UTILITY(U,$J,358.3,10068,2)
 ;;=^332786
 ;;^UTILITY(U,$J,358.3,10069,0)
 ;;=362.04^^79^675^33
 ;;^UTILITY(U,$J,358.3,10069,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10069,1,3,0)
 ;;=3^Mild Nonprolf Db Retnoph
 ;;^UTILITY(U,$J,358.3,10069,1,4,0)
 ;;=4^362.04
 ;;^UTILITY(U,$J,358.3,10069,2)
 ;;=^332787
 ;;^UTILITY(U,$J,358.3,10070,0)
 ;;=362.05^^79^675^34
 ;;^UTILITY(U,$J,358.3,10070,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10070,1,3,0)
 ;;=3^Mod Nonprolf Db Retinoph
 ;;^UTILITY(U,$J,358.3,10070,1,4,0)
 ;;=4^362.05
 ;;^UTILITY(U,$J,358.3,10070,2)
 ;;=^332788
 ;;^UTILITY(U,$J,358.3,10071,0)
 ;;=362.06^^79^675^52
 ;;^UTILITY(U,$J,358.3,10071,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10071,1,3,0)
 ;;=3^Sev Nonprolf Db Retinoph
 ;;^UTILITY(U,$J,358.3,10071,1,4,0)
 ;;=4^362.06
 ;;^UTILITY(U,$J,358.3,10071,2)
 ;;=^332789
 ;;^UTILITY(U,$J,358.3,10072,0)
 ;;=379.27^^79^675^56
 ;;^UTILITY(U,$J,358.3,10072,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10072,1,3,0)
 ;;=3^Vitreomacular Adhesion
 ;;^UTILITY(U,$J,358.3,10072,1,4,0)
 ;;=4^379.27
 ;;^UTILITY(U,$J,358.3,10072,2)
 ;;=^340517
 ;;^UTILITY(U,$J,358.3,10073,0)
 ;;=377.41^^79^676^23
 ;;^UTILITY(U,$J,358.3,10073,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10073,1,3,0)
 ;;=3^Optic Neuropathy, Ischemic
 ;;^UTILITY(U,$J,358.3,10073,1,4,0)
 ;;=4^377.41
 ;;^UTILITY(U,$J,358.3,10073,2)
 ;;=Optic Neuropathy, Ischemic^269231
 ;;^UTILITY(U,$J,358.3,10074,0)
 ;;=377.21^^79^676^20
 ;;^UTILITY(U,$J,358.3,10074,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10074,1,3,0)
 ;;=3^Drusen (ONH)
 ;;^UTILITY(U,$J,358.3,10074,1,4,0)
 ;;=4^377.21
 ;;^UTILITY(U,$J,358.3,10074,2)
 ;;=^269221
 ;;^UTILITY(U,$J,358.3,10075,0)
 ;;=377.10^^79^676^21
 ;;^UTILITY(U,$J,358.3,10075,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10075,1,3,0)
 ;;=3^Optic Atrophy
 ;;^UTILITY(U,$J,358.3,10075,1,4,0)
 ;;=4^377.10
 ;;^UTILITY(U,$J,358.3,10075,2)
 ;;=^85926
 ;;^UTILITY(U,$J,358.3,10076,0)
 ;;=377.30^^79^676^22
 ;;^UTILITY(U,$J,358.3,10076,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10076,1,3,0)
 ;;=3^Optic Neuritis
 ;;^UTILITY(U,$J,358.3,10076,1,4,0)
 ;;=4^377.30
 ;;^UTILITY(U,$J,358.3,10076,2)
 ;;=^86002
 ;;^UTILITY(U,$J,358.3,10077,0)
 ;;=377.01^^79^676^24
 ;;^UTILITY(U,$J,358.3,10077,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10077,1,3,0)
 ;;=3^Papilledema
 ;;^UTILITY(U,$J,358.3,10077,1,4,0)
 ;;=4^377.01
 ;;^UTILITY(U,$J,358.3,10077,2)
 ;;=Papilledema Associated with Increased Intracranial Pressure^269212
 ;;^UTILITY(U,$J,358.3,10078,0)
 ;;=368.40^^79^676^18
 ;;^UTILITY(U,$J,358.3,10078,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10078,1,3,0)
 ;;=3^Visual Field Defect
 ;;^UTILITY(U,$J,358.3,10078,1,4,0)
 ;;=4^368.40
 ;;^UTILITY(U,$J,358.3,10078,2)
 ;;=Visual Field Defect^126859
 ;;^UTILITY(U,$J,358.3,10079,0)
 ;;=379.40^^79^676^16
 ;;^UTILITY(U,$J,358.3,10079,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10079,1,3,0)
 ;;=3^Pupil, Abnormal Function
 ;;^UTILITY(U,$J,358.3,10079,1,4,0)
 ;;=4^379.40
 ;;^UTILITY(U,$J,358.3,10079,2)
 ;;=Pupil, Abnormal Function^101288
 ;;^UTILITY(U,$J,358.3,10080,0)
 ;;=362.34^^79^676^1
 ;;^UTILITY(U,$J,358.3,10080,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10080,1,3,0)
 ;;=3^Amaurosis Fugax
 ;;^UTILITY(U,$J,358.3,10080,1,4,0)
 ;;=4^362.34
 ;;^UTILITY(U,$J,358.3,10080,2)
 ;;=Amaurosis Fugax^268622
 ;;^UTILITY(U,$J,358.3,10081,0)
 ;;=351.0^^79^676^2
 ;;^UTILITY(U,$J,358.3,10081,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10081,1,3,0)
 ;;=3^Bell's Palsy
 ;;^UTILITY(U,$J,358.3,10081,1,4,0)
 ;;=4^351.0
 ;;^UTILITY(U,$J,358.3,10081,2)
 ;;=Bell's Palsy^13238
 ;;^UTILITY(U,$J,358.3,10082,0)
 ;;=333.81^^79^676^3
 ;;^UTILITY(U,$J,358.3,10082,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10082,1,3,0)
 ;;=3^Blepharospasm
 ;;^UTILITY(U,$J,358.3,10082,1,4,0)
 ;;=4^333.81
 ;;^UTILITY(U,$J,358.3,10082,2)
 ;;=Blepharospasm^15293
 ;;^UTILITY(U,$J,358.3,10083,0)
 ;;=437.9^^79^676^4
 ;;^UTILITY(U,$J,358.3,10083,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10083,1,3,0)
 ;;=3^Cerebrovascular Dis
 ;;^UTILITY(U,$J,358.3,10083,1,4,0)
 ;;=4^437.9
 ;;^UTILITY(U,$J,358.3,10083,2)
 ;;=Cerebrovascular Dis^21803
 ;;^UTILITY(U,$J,358.3,10084,0)
 ;;=368.2^^79^676^5
 ;;^UTILITY(U,$J,358.3,10084,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10084,1,3,0)
 ;;=3^Diplopia
 ;;^UTILITY(U,$J,358.3,10084,1,4,0)
 ;;=4^368.2
 ;;^UTILITY(U,$J,358.3,10084,2)
 ;;=Diplopia^35208
 ;;^UTILITY(U,$J,358.3,10085,0)
 ;;=378.53^^79^676^27
 ;;^UTILITY(U,$J,358.3,10085,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10085,1,3,0)
 ;;=3^Fourth Nerve Paresis
